EE380 Budget-Impact Analysis of Encorafenib with Binimetinib for Unresectable or Metastatic Melanoma in BRAFV600-Mutated Patients in an Argentinian Social Security Payer Setting
Abstract
Authors
C. Vega L. Rey Ares G. Correa Zeballos M.P. Ascarate P. Macadam N. Jorgensen